HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the journal, please login or register as reader.

2017 Issues

Cover

Vol. 19 • No. N1 • February 2017

In this issue:

  • Severe Trauma among Substance Users in Opioid Maintenance Treatment: Users' Assessment of Worst Trauma and Clinical Assessment of PTSD.
    Kjøsnes R., Waal H., Hauff E., and Gossop M.
  • GDNF Serum Levels Are Decreased in Opioid-Maintained Patients
    Groh A., Janke E., Rehme M., Schuster R., Lichtinghagen R., Frieling H., Bleich S., Hillemacher T., and Heberlein A.
  • Characteristics of Patients Accessing NHS Lanarkshire Addiction Services for the Treatment of Opioid Analgesic Dependence
    Hill D.
  • Understanding Diversion of Prescribed Opioid Agonist Medications in Birmingham, Uk—Prevalence and Predictors of Diversion
    Ratcliffe K., Chopra B., and Day E.
  • Directly Observed Rivaroxaban Therapy for Recurrent Venous Thromboembolism Integrated into Methadone Maintenance. A Case Report.
    Weichert I.
  • Prevalence and Risk Factors for Hepatitis C Viral Infection Amongst a Cohort of Irish Drug Users Attending a Drug Treatment Centre for Agonist Opioid Treatment (AOT).
    Keegan D., Crowley D., Laird E., and Van Hout M.C.
  • Towards Best Practice: Trends in the Management of Opioid Analgesic Dependence. Meeting Report.
    Alam F., D'Agnone O., Bremner D., Tuckey G., Abbasi Y., and Littlewood R.

 

Cover

Vol. 19 • No. N2 • April 2017

In this issue:

  • Staff regard towards working with patients with co-morbid depression and substance misuse: an exploratory study
    Nutt R., Gilchrist G., Marsa-Sambola F., and Baldacchino A.
  • The Role and Function of Heroin-Assisted Treatment at the Treatment System Level
    Uchtenhagen A.
  • Effectiveness of Pharmacotherapies in Increasing Treatment Retention and Reducing Opioid Overdose Death in Individuals Recently Released from Prison: A Systematic Review.
    Crowley D., and Van Hout M.C.
  • Ten Years of Psychological Research on Heroin Addiction and Related Problems at the New Bulgarian University: An Overview
    Todorov O., Psederska E., and Milcheva A.
  • Psychological Changes among Male Drug Dependent Offenders in a Prison-Based Therapeutic Community Programme
    Powis B., Randhawa K., and Gossop M.
  • Psychosocial Determinants in the Treatment of Opioid Use Disorder with Buprenorphine:  an Overview of the Literature
    Phelan J.
  • How to Improve a Poorly Running Agonist Opioid Treatment. Part 3: realistic Goals
    Ulmer A., and Meinhold C.

 

Cover

Vol. 19 • No. N3 • June 2017

In this issue:

  • Association between Serum Concentrations of Natriuretic Peptides and Perceived Withdrawal Symptoms in Opiate Maintenance
    Schuster R., Glahn A., Heberlein A., Rehme M.-K., Kleimann A., Lichtinghagen R., Koopmann A., Bleich S., and Hillemacher T.
  • Enhancing Knowledge and Reducing Barriers Improve Hepatitis C Management in Methadone Maintenance Treatment Patients
    Peles E., Adelson M., Sason A., Katchman H., Bruck R., Levit S., Schreiber S., and Shibolet O.
  • Methadone Maintenance Therapy Users' Knowledge and Attitudes toward the Methadone Maintenance Therapy: A Meta-Analysis
    Yee A., Loh H.S., Tan J.T., Tan A., and How M.Y.
  • Drug Addiction and Emotion Dysregulation in Young Adults
    Parolin M., Simonelli A., Cristofalo P., Sacco M., Bacciardi S., Maremmani A.G.I., Cimino S., Trumello C., and Cerniglia L.
  • Neuropsychological Deficits in Young Drug-Addicts
    Parolin M., Simonelli A., Cristofalo P., Mapelli D., Bacciardi S., Maremmani A.G.I., Cimino S., Babore A., and Cerniglia L.
  • The Influence of Comorbid Personality Disorder on Patients in Heroin-Assisted Treatment: Pilot Data on Clinical Outcome
    Dammann G., Gerber H., Denier N., Schmid O., Huber C., Riecher-Rössler A., Wiesbeck G.A., Borgwardt S.J., Gremaud-Heitz D., and Walter M.
  • Incidence of Cancer and Cancer Related Mortality in Opiate Dependent Patients Treated with Methadone, Buprenorphine or Implant Naltrexone as Compared with Non-Opiate Using Controls
    Kelty E., Dobbins T., and Hulse G.

 

Cover

Vol. 19 • No. N4 • August 2017

In this issue:

  • Substantial Improvement in Outpatient Opiate-Free Exits Using a Novel Resource-Efficient Lofexidine and Buprenorphine-Based Protocol (‘Detox-in-a-Box') – a Service Evaluation Study
    Iosub R., Seeger I., Law F., Wallbank N., and Melichar J.
  • Novel Approach to Predicting the Likelihood of Sustained Abstinence in Heroin Addicts Treated with Naltrexone and Naltrexone-Behavioural Therapy
    Knežević Tasić J., Karleuša Valkanou M., Đukanović B., Banković D., and Janjić V.
  • Effectiveness of Cognitive-Behavioural Stress Management on Self-Efficacy and Relapse of Substance Use Disorders Symptoms
    Solati K., and Hasanpour-Dehkordi A.
  • Exploring Predictors of Response to Methadone Maintenance Treatment for Heroin Addiction: The Role of Patient Satisfaction with Methadone as a Medication
    Alcaraz S., Trujols J., Siñol N., Duran-Sindreu S., Batlle F., and Pérez de los Cobos J.
  • Clinical Determination of Carbohydrate-Deficient Transferrin (Cdt) in a Random Sample of General Population in Naples
    Reccia L., Morelli R., Boccella S., Iovine R., Zaia D., Crinisio A., Leone A., Marabese I., Scala G., Guida F., Cante D., De Novellis V., and Stella L.
  • Experience of Drug Overdose at an Urban Addiction Clinic in Ireland
    Barry T., Crowley D., Benton A., Barron E., and O'Reilly F.
  • Patterns of Prescription Drug Use and Misuse in Spain: The European Opioid Treatment Patient Survey
    Fonseca F., Torrens M., Farré M., McBride K.E., Guareschi M., Touzeau D., Villeger P., Benyamina A., Dagnone O., Somaini L., Maremmani I., and Dart R.C.

 

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465
Tel/Phone: 0584 - 790073 - Fax: 0584-72081 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page